Results for tag: "Ofev"

Ofev is a prescription medication used to treat idiopathic pulmonary fibrosis (IPF), a chronic and progressive lung disease. It is a tyrosine kinase inhibitor that works by blocking the activity of certain proteins that are involved in the development of IPF. Ofev is the only approved medication for IPF in the United States and is available in tablet form. The Ofev market is a subset of the larger respiratory drugs market, which includes medications used to treat a variety of respiratory conditions, such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Ofev is the only approved medication for IPF, and as such, it has a unique position in the respiratory drugs market. Some companies in the Ofev market include Boehringer Ingelheim, which manufactures the drug, as well as other pharmaceutical companies that market and distribute the medication. Additionally, there are a number of healthcare providers and organizations that provide support and resources for patients taking Ofev. Show Less Read more